National Institutes of Health
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) is a funding opportunity from National Institutes of Health, up to $25.0M, closing January 6, 2028.
Overview
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high-quality nonmalignant hematology research relevant to the missions of the National Institute of Diabetes and…